VeriMom¿Es tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 seguro durante el embarazo?
No harmonised CLP reproductive classifications (ECHA Annex VI) or CIR/SCCS safety opinions listing reproductive hazard for these cosmetic peptides. Peer‑reviewed and regulatory sources for cosmetic peptides (e.g., oligopeptides/dipeptides/tripeptides used in topical products) do not report teratogenicity or reproductive toxicity; large peptide size and intended topical use make systemic reproductive hazard unlikely (sources: ECHA Annex VI — no harmonised H360/H361, CosIng/PubChem entries show cosmetic peptide use, no CIR/SCCS reproductive findings).
Related ingredients
Frequently asked questions
- ¿Es tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 seguro durante el embarazo?
- No harmonised CLP reproductive classifications (ECHA Annex VI) or CIR/SCCS safety opinions listing reproductive hazard for these cosmetic peptides. Peer‑reviewed and regulatory sources for cosmetic peptides (e.g., oligopeptides/dipeptides/tripeptides used in topical products) do not report teratogenicity or reproductive toxicity; large peptide size and intended topical use make systemic reproductive hazard unlikely (sources: ECHA Annex VI — no harmonised H360/H361, CosIng/PubChem entries show cosmetic peptide use, no CIR/SCCS reproductive findings).
- ¿Es tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 seguro durante la lactancia?
- No data indicating reproductive or lactation hazards, no regulatory classifications for breastfeeding risk. Topical cosmetic peptides are large molecules with low dermal penetration in available literature and no evidence of transfer into breast milk or lactation-specific adverse effects in human studies or regulatory assessments (sources: CosIng, PubChem, absence of SCCS/CIR concerns).
- ¿Es tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 seguro para la piel del bebé?
- No evidence of developmental or infant‑specific reproductive toxicity. Peptides used in cosmetics are high molecular weight and generally show negligible dermal absorption; therefore exposure to infants (0–3 yr) from typical topical cosmetic use is expected to be minimal and no infant‑specific hazard is documented. No harmonised CLP flags or published infant toxicity data were found (sources: CosIng, PubChem, PubMed literature absence).
- ¿Cómo puntúa VeriMom a tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1?
- VeriMom puntúa tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 en el embarazo?
- Consulta nuestra lista de alternativas seguras a tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.